BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 17161895)

  • 1. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.
    Thiermann H; Szinicz L; Eyer P; Felgenhauer N; Zilker T; Worek F
    Toxicology; 2007 Apr; 233(1-3):145-54. PubMed ID: 17161895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
    Jokanović M
    Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N; Thiermann H; Szinicz L; Worek F
    Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
    Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes.
    Balali-Mood M; Shariat M
    J Physiol Paris; 1998; 92(5-6):375-8. PubMed ID: 9789840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
    Worek F; Szinicz L; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oximes in the management of organophosphorus pesticide poisoning.
    Eyer P
    Toxicol Rev; 2003; 22(3):165-90. PubMed ID: 15181665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oximes in the treatment of nerve agent poisoning in civilian casualties.
    Marrs TC; Rice P; Vale JA
    Toxicol Rev; 2006; 25(4):297-323. PubMed ID: 17288500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation of cholinesterase status at different scenarios of nerve agent exposure.
    Worek F; Eyer P; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):155-65. PubMed ID: 16904807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.
    Wilhelm CM; Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):254-65. PubMed ID: 25448441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organophosphorus poisoning.
    Paudyal BP
    JNMA J Nepal Med Assoc; 2008; 47(172):251-8. PubMed ID: 19079407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oximes in organophosphate poisoning: 60 years of hope and despair.
    Worek F; Thiermann H; Wille T
    Chem Biol Interact; 2016 Nov; 259(Pt B):93-98. PubMed ID: 27125761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
    Bajgar J; Fusek J; Bartosova L; Jun D; Kuca K
    J Appl Toxicol; 2006; 26(5):439-43. PubMed ID: 16915560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of novel oximes for treatment of poisoning by organophosphorus compounds.
    Worek F; Thiermann H
    Pharmacol Ther; 2013 Aug; 139(2):249-59. PubMed ID: 23603539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.